Chapter 4 Diseases Associated with Mutations of the Human Lutropin Receptor

Progress in Molecular Biology and Translational Science

Volumn 89, Issue C, 2009, Pages 97-114

  Segaloff, Deborah L ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

46,XY disorders of sexual development; Glycoprotein hormone receptor; Gonadotropin receptor; Infertility; LH receptor; Luteinizing hormone receptor; Lutropin receptor; Precocious puberty; Testotoxicosis

Indexed keywords

LUTEINIZING HORMONE RECEPTOR;

GENERAL ASPECTS OF DISEASE; GENETIC PREDISPOSITION; GENETICS; HUMAN; MUTATION; PHYSIOLOGICAL PROCESS; REVIEW;

DISEASE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; PHYSIOLOGICAL PHENOMENA; RECEPTORS, LH;

EID: 77957073672     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1877-1173(09)89004-2     Document Type: Review

References (97)

1. Ascoli M., Fanelli F., and Segaloff D.L. The lutropin/choriogonadotropin receptor, a 2002 perspective. Endocr Rev 23 (2002) 141-174
2. Vassart G., Pardo L., and Costagliola S. A molecular dissection of the glycoprotein hormone receptors. Trends Biochem Sci 29 (2004) 119-126
3. Latronico A., and Segaloff D. Naturally occurring mutations of the luteinizing hormone receptor: lessons learned about reproductive physiology and G protein-coupled receptors. Am J Hum Genet 65 (1999) 949-958
4. Themmen A.PN., and Huhtaniemi I.T. Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocr Rev 21 (2000) 551-583
5. Themmen A.P. An update of the pathophysiology of human gonadotrophin subunit and receptor gene mutations and polymorphisms. Reproduction 130 (2005) 263-274
6. Piersma D., Verhoef-Post M., Berns E.M., and Themmen A.P. LH receptor gene mutations and polymorphisms: an overview. Mol Cell Endocrinol 260-262 (2007) 282-286
7. Kleinau G., Brehm M., Wiedemann U., Labudde D., Leser U., and Krause G. Implications for molecular mechanisms of glycoprotein hormone receptors using a new sequence-structure-function analysis resource. Mol Endocrinol 21 (2007) 574-580
8. Van Durme J., Horn F., Costagliola S., Vriend G., and Vassart G. GRIS: glycoprotein-hormone receptor information system. Mol Endocrinol 20 (2006) 2247-2255
9. Apaja P.M., Harju K.T., Aatsinki J.T., Petaja-Repo U.E., and Rajaniemi H.J. Identification and structural characterization of the neuronal luteinizing hormone receptor associated with sensory systems. J Biol Chem 279 (2004) 1899-1906
10. Xie Y.B., Wang H., and Segaloff D.L. Extracellular domain of lutropin/choriogonadotropin receptor expressed in transfected cells binds choriogonadotropin with high affinity. J Biol Chem 265 (1990) 21411-21414
11. McFarland K.C., Sprengel R., Phillips H.S., Kohler M., Rosemblit N., Nikolics K., et al. Lutropin-choriogonadotropin receptor: an unusual member of the G protein-coupled receptor family. Science 245 (1989) 494-499
12. Fan Q.R., and Hendrickson W.A. Structure of human follicle-stimulating hormone in complex with its receptor. Nature 433 (2005) 269-277
13. Onaran H.O., Scheer A., Cotecchia S., and Costa T. A look into receptor efficacy: from the signalling network of the cell to the intramolecular motion of the receptor. In: Kenakin T., and Angus J.A. (Eds). The Pharmacology of functional, biochemical, and recombinant receptor systems (2000), Springer, Berlin 217-259
14. Kenakin T. Efficacy at G-protein-coupled receptors. Nat Rev Drug Discov 1 (2002) 103-110
15. Kobilka B.K., and Deupi X. Conformational complexity of G-protein-coupled receptors. Trends Pharmacol Sci 28 (2007) 397-406
16. Hirakawa T., Galet C., and Ascoli M. MA-10 cells transfected with the human lutropin/choriogonadotropin receptor (hLHR): a novel experimental paradigm to study the functional properties of the hLHR. Endocrinology 143 (2002) 1026-1035
17. Donadeu F.X., and Ascoli M. The differential effects of the gonadotropin receptors on aromatase expression in primary cultures of immature rat granulosa cells are highly dependent on the density of receptors expressed and the activation of the inositol phosphate cascade. Endocrinology 146 (2005) 3907-3916
18. Andric N., and Ascoli M. Mutations of the lutropin/choriogonadotropin receptor that do not activate the phosphoinositide cascade allow hCG to induce aromatase expression in immature rat granulosa cells. Mol Cell Endocrinol 285 (2008) 62-72
19. Hirakawa T., and Ascoli M. A constitutively active somatic mutation of the human lutropin receptor found in Leydig cell tumors activates the same families of G proteins as germ line mutations associated with Leydig cell hyperplasia. Endocrinology 144 (2003) 3872-3878
20. Bruysters M., Verhoef-Post M., and Themmen A.P. Asp330 and Tyr331 in the C-terminal cysteine-rich region of the luteinizing hormone receptor are key residues in hormone-induced receptor activation. J Biol Chem 283 (2008) 25821-25828
21. Agrawal G., and Dighe R.R. Critical involvement of the hinge region of the follicle-stimulating hormone receptor in the activation of the receptor. J Biol Chem 284 (2009) 2636-2647
22. Mizutori Y., Chen C.R., McLachlan S.M., and Rapoport B. The thyrotropin receptor hinge region is not simply a scaffold for the leucine-rich domain but contributes to ligand binding and signal transduction. Mol Endocrinol 22 (2008) 1171-1182
23. Palczewski K., Kumasaka T., Hori T., Behnke C.A., Motoshima H., Fox B.A., et al. Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289 (2000) 739-745
24. Park J.H., Scheerer P., Hofmann K.P., Choe H.W., and Ernst O.P. Crystal structure of the ligand-free G-protein-coupled receptor opsin. Nature 454 (2008) 183-187
25. Scheerer P., Park J.H., Hildebrand P.W., Kim Y.J., Krauss N., Choe H.W., et al. Crystal structure of opsin in its G-protein-interacting conformation. Nature 455 (2008) 497-502
26. Cherezov V., Rosenbaum D.M., Hanson M.A., Rasmussen S.G., Thian F.S., Kobilka T.S., et al. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 318 (2007) 1258-1265
27. Rosenbaum D.M., Cherezov V., Hanson M.A., Rasmussen S.G., Thian F.S., Kobilka T.S., et al. GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function. Science 318 (2007) 1266-1273
28. Rasmussen S.G., Choi H.J., Rosenbaum D.M., Kobilka T.S., Thian F.S., Edwards P.C., et al. Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature 450 (2007) 383-387
29. Warne T., Serrano-Vega M.J., Baker J.G., Moukhametzianov R., Edwards P.C., Henderson R., et al. Structure of a beta1-adrenergic G-protein-coupled receptor. Nature 454 (2008) 486-491
30. Jaakola V.P., Griffith M.T., Hanson M.A., Cherezov V., Chien E.Y., Lane J.R., et al. The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science 322 (2008) 1211-1217
31. Fan Q.R., and Hendrickson W.A. Assembly and structural characterization of an authentic complex between human follicle stimulating hormone and a hormone-binding ectodomain of its receptor. Mol Cell Endocrinol 260-262 (2007) 73-82
32. Rousseau-Merck M.F., Misrahi M., Atger M., Loosfelt H., Milgrom E., and Berger R. Localization of the human luteinizing hormone/choriogonadotropin receptor gene (LHCGR) to chromosome 2p21. Cytogenet Cell Genet 54 (1990) 77-79
33. Kossack N., Simoni M., Richter-Unruh A., Themmen A.P., and Gromoll J. Mutations in a novel, cryptic exon of the luteinizing hormone/chorionic gonadotropin receptor gene cause male pseudohermaphroditism. PLoS Med 5 (2008) e88
34. Shenker A., Laue L., Kosugi S., Merendino Jr. J.J., Minegishi T., and Cutler Jr. G.B. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 365 (1993) 652-654
35. Laue L., Chan W.-C., Hsueh A., Kudo M., Hsu S.Y., Wu S., et al. Genetic heterogeneity of constitutively activating mutations of the human luteinizing hormone receptor in familial male-limited precocious puberty. Proc Natl Acad Sci USA 92 (1995) 1906-1910
36. Liu G., Duranteau L., Carel J.-C., Monroe J., Doyle D.A., and Shenker A. Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor. N Engl J Med 341 (1999) 1731-1736
37. Richter-Unruh A., Wessels H.T., Menken U., Bergmann M., Schmittmann-Ohters K., Schaper J., et al. Male LH-independent sexual precocity in a 3.5-year-old boy caused by a somatic activating mutation of the LH receptor in a Leydig cell tumor. J Clin Endocrinol Metab 87 (2002) 1052-1056
38. Kiepe D., Richter-Unruh A., Autschbach F., Kessler M., Schenk J.P., and Bettendorf M. Sexual pseudo-precocity caused by a somatic activating mutation of the LH receptor preceding true sexual precocity. Horm Res 70 (2008) 249-253
39. Rosenthal I.M., Refetoff S., Rich B., Barnes R.B., Sunthornthepvarakul T., Parma J., et al. Response to challenge with gonadotropin-releasing hormone agonist in a mother and her two sons with a constitutively activating mutation of the luteinizing hormone receptor-A clinical research center study. J Clin Endocrinol Metab 81 (1996) 3802-3806
40. Latronico A.C., Shinozaki H., Guerra Jr. G., Pereira M.A., Lemos Marini S.H., Baptista M.T., et al. Gonadotropin-independent precocious puberty due to luteinizing hormone receptor mutations in Brazilian boys: a novel constitutively activating mutation in the first transmembrane helix. J Clin Endocrinol Metab 85 (2000) 4799-4805
41. Latronico A.C., Lins T.S., Brito V.N., Arnhold I.J., and Mendonca B.B. The effect of distinct activating mutations of the luteinizing hormone receptor gene on the pituitary-gonadal axis in both sexes. Clin Endocrinol (Oxf) 53 (2000) 609-613
42. Latronico A.C., Abell A.N., Arnhold I.JP., Liu X., Lins T.SS., Brito V.N., et al. A unique constitutively activating mutation in the third transmembrane helix of the luteinizing hormone receptor causes sporadic male gonadotropin independent precocious puberty. J Clin Endocrinol Metab 83 (1998) 2435-2440
43. Latronico A.C., and Segaloff D.L. Insights learned from the L457(3.43)R, an activating mutant of the human lutropin receptor. Mol Cell Endocrinol 260-262 (2007) 287-293
44. Zhang M., Tao Y.X., Ryan G.L., Feng X., Fanelli F., and Segaloff D.L. Intrinsic differences in the response of the human lutropin receptor versus the human follitropin receptor to activating mutations. J Biol Chem 282 (2007) 25527-25539
45. Vasseur C., Rodien P., Beau I., Desroches A., Gerard C., de Poncheville L., et al. A chorionic gonadotropin-sensitive mutation in the follicle-stimulating hormone receptor as a cause of familial gestational spontaneous ovarian hyperstimulation syndrome. N Engl J Med 349 (2003) 753-759
46. Smits G., Olatunbosun O., Delbaere A., Pierson R., Vassart G., and Costagliola S. Ovarian hyperstimulation syndrome due to a mutation in the follicle-stimulating hormone receptor. N Engl J Med 349 (2003) 760-766
47. Montanelli L., Delbaere A., Di Carlo C., Nappi C., Smits G., Vassart G., et al. A mutation in the follicle-stimulating hormone receptor as a cause of familial spontaneous ovarian hyperstimulation syndrome. J Clin Endocrinol Metab 89 (2004) 1255-1258
48. Montanelli L., Van Durme J.J., Smits G., Bonomi M., Rodien P., Devor E.J., et al. Modulation of ligand selectivity associated with activation of the transmembrane region of the human follitropin receptor. Mol Endocrinol 18 (2004) 2061-2073
49. De Leener A., Montanelli L., Van Durme J., Chae H., Smits G., Vassart G., et al. Presence and absence of follicle-stimulating hormone receptor mutations provide some insights into spontaneous ovarian hyperstimulation syndrome physiopathology. J Clin Endocrinol Metab 91 (2006) 555-562
50. Angelova K., Fanelli F., and Puett D. A model for constitutive lutropin receptor activation based on molecular simulation and engineered mutations in transmembrane helices 6 and 7. J Biol Chem 277 (2002) 32202-32213
51. Fanelli F., Verhoef-Post M., Timmerman M., Zeilemaker A., Martens J.W., and Themmen A.P. Insight into mutation-induced activation of the luteinizing hormone receptor: molecular simulations predict the functional behavior of engineered mutants at M398. Mol Endocrinol 18 (2004) 1499-1508
52. Zhang M., Mizrachi D., Fanelli F., and Segaloff D.L. The formation of a salt bridge between helices 3 and 6 is responsible for the constitutive activity and lack of hormone responsiveness of the naturally occurring L457R mutation of the human lutropin receptor. J Biol Chem 280 (2005) 26169-26176
53. Fanelli F., and De Benedetti P.G. Computational modeling approaches to structure-function analysis of G protein-coupled receptors. Chem Rev 105 (2005) 3297-3351
54. Feng X., Muller T., Mizrachi D., Fanelli F., and Segaloff D.L. An intracellular loop (IL2) residue confers different basal constitutive activities to the human lutropin receptor and human thyrotropin receptor through structural communication between IL2 and helix 6, via helix 3. Endocrinology 149 (2008) 1705-1717
55. Abell A.N., and Segaloff D.L. Evidence for the direct involvement of transmembrane region 6 of the lutropin/choriogonadotropin receptor in activating Gs. J Biol Chem 272 (1997) 14586-14591
56. Tao Y.X., Johnson N.B., and Segaloff D.L. Constitutive and agonist-dependent self-association of the cell surface human lutropin receptor. J Biol Chem 279 (2004) 5904-5914
57. Guan R., Feng X., Wu X., Zhang M., Zhang X., Hebert T.E., et al. Bioluminescence resonance energy transfer studies reveal constitutive dimerization of the human lutropin receptor and a lack of correlation between receptor activation and the propensity for dimerization. J Biol Chem 284 (2009) 7483-7494
58. Martens J.WM., Verhoef-Post M., Abelin N., Ezabella M., Toledo S.PA., Brunner H.G., et al. A homozygous mutation of the luteinizing hormone receptor causes partial Leydig cell hypoplasia: correlation between receptor activity and phenotype. Mol Endocrinol 12 (1998) 775-784
59. Latronico A.C., Chai Y., Arnhold I.JP., Liu X., Mendonca B.B., and Segaloff D.L. A homozygous microdeletion in helix 7 of the luteinizing hormone receptor associated with familial testicular and ovarian resistance is due to both decreased cell surface expresssion and impaired effector activation by the cell surface receptor. Mol Endocrinol 12 (1998) 442-450
60. Mizrachi D., and Segaloff D.L. Intracellularly located misfolded glycoprotein hormone receptors associate with different chaperone proteins than their cognate wild-type receptors. Mol Endocrinol 18 (2004) 1768-1777
61. Harwood J.P., Conti M., Conn P.M., Dufau M.L., and Catt K.J. Receptor regulation and target cell responses: studies in the ovarian luteal cell. Mol Cell Endocrinol 11 (1978) 121-135
62. Catt K.J., Harwood J.P., Clayton R.N., Davies T.F., Chan V., Katikineni M., et al. Regulation of peptide hormone receptors and gonadal steroidogenesis. Recent Prog Horm Res 36 (1980) 557-622
63. Bruysters M., Christin-Maitre S., Verhoef-Post M., Sultan C., Auger J., Faugeron I., et al. A new LH receptor splice mutation responsible for male hypogonadism with subnormal sperm production in the propositus, and infertility with regular cycles in an affected sister. Hum Reprod 23 (2008) 1917-1923
64. Gromoll J., Eiholzer U., Nieschlag E., and Simoni M. Male hypogonadism caused by homozygous deletion of exon 10 of the luteinizing hormone (LH) receptor: differential action of human chorionic gonadotropin and LH. J Clin Endocrinol Metab 85 (2000) 2281-2286
65. Muller T., Gromoll J., and Simoni M. Absence of exon 10 of the human luteinizing hormone (LH) receptor impairs LH, but not human chorionic gonadotropin action. J Clin Endocrinol Metab 88 (2003) 2242-2249
66. Richter-Unruh A., Korsch E., Hiort O., Holterhus P.M., Themmen A.P., and Wudy S.A. Novel insertion frameshift mutation of the LH receptor gene: problematic clinical distinction of Leydig cell hypoplasia from enzyme defects primarily affecting testosterone biosynthesis. Eur J Endocrinol 152 (2005) 255-259
67. Richter-Unruh A., Martens J.W., Verhoef-Post M., Wessels H.T., Kors W.A., Sinnecker G.H., et al. Leydig cell hypoplasia: cases with new mutations, new polymorphisms and cases without mutations in the luteinizing hormone receptor gene. Clin Endocrinol (Oxf) 56 (2002) 103-112
68. Gromoll J., Partsch C.-J., Simoni M., Nordhoff V., Sippell W.G., Nieschlag E., et al. A mutation in the first transmembrane domain of the lutropin receptor causes male precocious puberty. J Clin Endocrinol Metab 83 (1998) 476-480
69. Evans B.AJ., Bowen D.J., Smith P.J., Clayton P.E., and Gregory J.W. A new point mutation in the luteinising hormone receptor gene in familial and sporadic male limited precocious puberty: genotype does not always correlate with phenotype. J Med Genet 33 (1996) 143-147
70. Kraaij R., Post M., Kremer H., Milgrom E., Epping W., Brunner H.G., et al. A missense mutation in the second transmembrane segment of the luteinizing hormone receptor causes familiar male precocious puberty. J Clin Endocrinol Metab 80 (1995) 3168-3172
71. Yano K., Kohn L.D., Saji M., Kataoka N., Okuno A., and Cutler Jr. G.B. A case of male-limited precocious puberty caused by a point mutation in the second transmembrane domain of the luteinizing hormone choriogonadotropin receptor gene. Biochem Biophys Res Commun 220 (1996) 1036-1042
72. Ignacak M., Hilczer M., Zarzycki J., and Trzeciak W.H. Substitution of M398T in the second transmembrane helix of the LH receptor in a patient with familial male-limited precocious puberty. Endocr J 47 (2000) 595-599
73. Kremer H., Martens J.W., van Reen M., Verhoef-Post M., Wit J.M., Otten B.J., et al. A limited repertoire of mutations of the luteinizing hormone (LH) receptor gene in familial and sporadic patients with male LH-independent precocious puberty. J Clin Endocrinol Metab 84 (1999) 1136-1140
74. Latronico A.C., Anasti J., Arnhold I.JP., Mendonca B.B., Domenice S., Albano M.C., et al. A novel mutation of the luteinizing hormone receptor gene causing male gonadotropin-independent precocious puberty. J Clin Endocrinol Metab 80 (1995) 2490-2494
75. Kremer H., Mariman E., Otten B.J., Moll Jr. G.W., Stoelinja G.B., Wit J.M., et al. Cosegregation of missense mutations of the luteinizing hormone receptor gene with familial male-limited precocious puberty. Hum Mol Genet 2 (1993) 1779-1783
76. Kosugi S., Van Dop C., Geffner M.E., Rabl W., Carel J.C., Chaussain J.L., et al. Characterization of heterogeneous mutations causing constitutive activation of the luteinizing hormone receptor in familial male precocious puberty. Hum Mol Genet 4 (1995) 183-188
77. Yano K., Saji M., Hidaka A., Moriya N., Okuno A., Kohn L.D., et al. A new constitutively activating point mutation in the luteinizing hormone/choriogonadotropin receptor gene in cases of male-limited precocious puberty. J Clin Endocrinol Metab 80 (1995) 1162-1168
78. Laue L., Wu S.M., Kudo M., Hsueh A.JW., Cutler G.B., Jelly D.H., et al. Heterogeneity of activating mutations of the human luteinizing hormone receptor in male-limited precocious puberty. Biochem Mol Med 58 (1996) 192-198
79. Cocco S., Meloni A., Marini M.G., Cao A., and Moi P. A missense (T577I) mutation in the luteinizing hormone receptor gene associated with familial male-limited precocious puberty. Hum Mutat 7 (1996) 164-166
80. Yano K., Hidaka A., Saji M., Polymeropoulos M.H., Okuno A., Kohn L.D., et al. A sporadic case of male-limited precocious puberty has the same consitutively activating point mutation in luteinizing hormone/choriogonadotropin receptor gene as familial cases. J Clin Endocrinol Metab 79 (1994) 1818-1823
81. Kawate N., Kletter G.B., Wilson B.E., Netzloff M.L., and Menon K.MJ. Identification of constitutively activating mutation of the luteinising hormone receptor in a family with male limited gonadotrophin independent precocious puberty (testotoxicosis). J Med Genet 32 (1995) 553-554
82. Muller J., Gondos B., Kosugi S., Mori T., and Shenker A. Severe testotoxicosis phenotype associated with Asp578-->Tyr mutation of the lutrophin/choriogonadotrophin receptor gene. J Med Genet 35 (1998) 340-341
83. Wu S.M., Leschek E.W., Brain C., and Chan W.Y. A novel luteinizing hormone receptor mutation in a patient with familial male-limited precocious puberty: effect of the size of a critical amino acid on receptor activity. Mol Genet Metab 66 (1999) 68-73
84. Canto P., Soderlund D., Ramon G., Nishimura E., and Mendez J.P. Mutational analysis of the luteinizing hormone receptor gene in two individuals with Leydig cell tumors. Am J Med Genet 108 (2002) 148-152
85. Wu S.M., Hallermeier K.M., Laue L., Brain C., Berry C., Grant D.B., et al. Inactivation of the luteinizing hormone/chorionic gonadotropin receptor by an insertional mutation in Leydig cell hypoplasia. Mol Endocrinol 12 (1998) 1651-1660
86. Leung M.Y., Steinbach P.J., Bear D., Baxendale V., Fechner P.Y., Rennert O.M., et al. Biological effect of a novel mutation in the third leucine-rich repeat of human luteinizing hormone receptor. Mol Endocrinol 20 (2006) 2493-2503
87. Misrahi M., Meduri G., Pissard S., Bouvattier C., Beau I., Loosfelt H., et al. Comparison of immunocytochemical and molecular features with the phenotype in a case of incomplete male pseudohermaphroditism associated with a mutation of the luteinizing hormone receptor. J Clin Endocrinol Metab 82 (1997) 2159-2165
88. Richter-Unruh A., Verhoef-Post M., Malak S., Homoki J., Hauffa B.P., and Themmen A.P. Leydig cell hypoplasia: absent luteinizing hormone receptor cell surface expression caused by a novel homozygous mutation in the extracellular domain. J Clin Endocrinol Metab 89 (2004) 5161-5167
89. Gromoll J., Schulz A., Borta H., Gudermann T., Teerds K.J., Greschniok A., et al. Homozygous mutation within the conserved Ala-Phe-Asn-Glu-Thr motif of exon 7 of the LH receptor causes male pseudohermaphroditism. Eur J Endocrinol 147 (2002) 597-608
90. Laue L.L., Wu S.M., Kudo M., Bourony C.J., Cutler G.B., Hsueh A.JW., et al. Compound heterozygous mutations of the luteinizing hormone receptor gene in Leydig cell hypoplasia. Mol Endocrinol 10 (1996) 987-997
91. Martens J.W., Lumbroso S., Verhoef-Post M., Georget V., Richter-Unruh A., Szarras-Czapnik M., et al. Mutant luteinizing hormone receptors in a compound heterozygous patient with complete Leydig cell hypoplasia: abnormal processing causes signaling deficiency. J Clin Endocrinol Metab 87 (2002) 2506-2513
92. Stavrou S.S., Zhu Y.-S., Cai L.Q., Katz M.D., Herrara C., DeFillo-Ricart M., et al. A novel mutation of the human luteinizing hormone receptor in 46XY and 46XX sisters. J Clin Endocrinol Metab 83 (1998) 2091-2098
93. Pals-Rylaarsdam R., Liu G., Brickman W., Duranteau L., Monroe J., El-Awady M.K., et al. A novel double mutation in the luteinizing hormone receptor in a kindred with familial Leydig cell hypoplasia and male pseudohermaphroditism. Endocr Res 31 (2005) 307-323
94. Laue L., Wu S.M., Kudo M., Hsueh A.JW., Cutler Jr. G.B., Griffin J.E., et al. A nonsense mutation of the human luteinizing hormone receptor gene in Leydig cell hypoplasia. Hum Mol Genet 4 (1995) 1429-1433
95. Latronico A.C., Anasti J., Arnhold I.JP., Rapaport R., Mendonca B.B., Bloise W., et al. Testicular and ovarian resistance to luteinizing hormone caused by homozygous inactivating mutations of the luteinizing hormone receptor gene. N Engl J Med 334 (1996) 507-512
96. Toledo S.PA., Brunner H.G., Kraaij R., Post M., Dahia P.LM., Hayashida C.Y., et al. An inactivating mutation of the luteinizing hormone receptor causes amenorrhea in a 46, XX female. J Clin Endocrinol Metab 81 (1996) 3850-3854
97. Kremer H., Kraaij R., Toledo S.PA., Post M., Fridman J.B., Hayashida C.Y., et al. Male pseudohermaphroditism due to a homozygous missense mutation of the luteinizing hormone receptor gene. Nat Genet 9 (1995) 160-164